The predictive capabilities of these models were assessed using four distinct sets of genetic markers: (1) APOE-ε4 counts, (2) AD PRS, (3) a composite of multiple PRSs, and (4) select SNPs refined through Elastic Net regularization30. This evidence concerns the gene APOE and Alzheimer disease.